Article metrics

Download PDFPDF

769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022584051
Dec 2022231021
Jan 2023132010
Feb 2023192012
Mar 2023182011
Apr 20235407
May 20235806
Jun 20234506
Jul 202374011
Aug 20234304
Sep 20235805
Oct 20234002
Nov 20235607
Dec 202311609
Jan 20243803
Total19030165